André, S.; Larbanoix, L.; Verteneuil, S.; Stanicki, D.; Nonclercq, D.; Vander Elst, L.; Laurent, S.; Muller, R.N.; Burtea, C.
Development of an LDL Receptor-Targeted Peptide Susceptible to Facilitate the Brain Access of Diagnostic or Therapeutic Agents. Biology 2020, 9, 161.
https://doi.org/10.3390/biology9070161
AMA Style
André S, Larbanoix L, Verteneuil S, Stanicki D, Nonclercq D, Vander Elst L, Laurent S, Muller RN, Burtea C.
Development of an LDL Receptor-Targeted Peptide Susceptible to Facilitate the Brain Access of Diagnostic or Therapeutic Agents. Biology. 2020; 9(7):161.
https://doi.org/10.3390/biology9070161
Chicago/Turabian Style
André, Séverine, Lionel Larbanoix, Sébastien Verteneuil, Dimitri Stanicki, Denis Nonclercq, Luce Vander Elst, Sophie Laurent, Robert N. Muller, and Carmen Burtea.
2020. "Development of an LDL Receptor-Targeted Peptide Susceptible to Facilitate the Brain Access of Diagnostic or Therapeutic Agents" Biology 9, no. 7: 161.
https://doi.org/10.3390/biology9070161
APA Style
André, S., Larbanoix, L., Verteneuil, S., Stanicki, D., Nonclercq, D., Vander Elst, L., Laurent, S., Muller, R. N., & Burtea, C.
(2020). Development of an LDL Receptor-Targeted Peptide Susceptible to Facilitate the Brain Access of Diagnostic or Therapeutic Agents. Biology, 9(7), 161.
https://doi.org/10.3390/biology9070161